Pernod Ricard shares tumbled 3% on Monday following a Deutsche Bank downgrade to "sell" from "hold," with analyst Mitch Collett arguing the 20% year-to-date rally has outpaced fundamentals. The spirits giant's first-half fiscal 2026 results showed organic sales down 5.9% and EBIT falling 7.5%, broadly in line with market expectations.

Collett's concern centers on valuation, noting Pernod trades at 15.2x CY2026 earnings with only a 14% discount to European Beverages peers, which he deems insufficient given the company's 3.8x net debt/EBITDA and uncertain growth outlook. The stock's recovery appears driven by positioning rather than fundamental improvement, as shares were heavily shorted.

The downgrade highlights two key risks: leverage and the embedded H2 recovery in consensus estimates. Management has committed to reducing net debt/EBITDA below 3x by FY2029, but this path depends on earnings recovery, continued disposals, and tight capital discipline over three years. Meanwhile, the projected 1.2% organic sales growth for H2 leans heavily on Chinese New Year timing and easier comparatives rather than genuine demand improvement.